Evidence map›Paper›PMID 34003868›Full record

ArticlePloS one2021

Metal-induced delayed type hypersensitivity responses potentiate particle induced osteolysis in a sex and age dependent manner.

Lauryn Samelko, Marco Caicedo, Kyron McAllister, Joshua Jacobs, Nadim James Hallab

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. MAVRIC based T2 mapping assessment of infrapatellar fat pad scarring in patients with total knee arthroplasty.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2023
    Article
  5. Therapeutic effects of MSCs, genetically modified MSCs, and NFĸB-inhibitor on chronic inflammatory osteolysis in aged mice.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2023
    Article
  6. Review
  7. Review
  8. Metallic Implants Used in Lumbar Interbody Fusion.Materials (Basel, Switzerland) · 2022
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Lauryn SamelkoDepartment of Orthopedic Surgery, Rush University Medical Center, Chicago, IL, United States of America.ORCID 0000-0003-2434-1793
Marco CaicedoDepartment of Orthopedic Surgery, Rush University Medical Center, Chicago, IL, United States of America.
Kyron McAllisterDepartment of Orthopedic Surgery, Rush University Medical Center, Chicago, IL, United States of America.
Joshua JacobsDepartment of Orthopedic Surgery, Rush University Medical Center, Chicago, IL, United States of America.
Nadim James HallabDepartment of Orthopedic Surgery, Rush University Medical Center, Chicago, IL, United States of America.ORCID 0000-0001-6421-2836
Rush University Medical Center · US

Funding

Inflammasome Danger Signaling:A Novel Target to Prevent Debris Induced OsteolysisR01AR060782 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI HALLAB, NADIM JAMES · 2012 to 2016
$1.5M
NIAMS NIH HHS R01 AR060782
6 · The paper itself

Abstract

It is widely recognized that innate macrophage immune reactions to implant debris are central to the inflammatory responses that drive biologic implant failure over the long term. Less common, adaptive lymphocyte immune reactions to implant debris, such as delayed type hypersensitivity (DTH), can also affect implant performance. It is unknown which key patient factors, if any, mediate these adaptive immune responses that potentiate particle/macrophage mediated osteolysis. The objective of this investigation was to determine to what degree known adaptive immune responses to metal implant debris can affect particle-induced osteolysis (PIO); and if this pathomechanism is dependent on: 1) innate immune danger signaling, i.e., NLRP3 inflammasome activity, 2) sex, and/or 3) age. We used an established murine calvaria model of PIO using male and female wild-type C57BL/6 vs. Caspase-1 deficient mice as well as young (12-16 weeks old) vs. aged (18-24 months old) female and male C57BL/6 mice. After induction of metal-DTH, and Cobalt-alloy particle (ASTM F-75, 0.4um median diameter) calvaria challenge, bone resorption was assessed using quantitative micro-computed tomography (micro-CT) analysis and immune responses were assessed by measuring paw inflammation, lymphocyte transformation test (LTT) reactivity and adaptive immune cytokines IFN-gamma and IL-17 (ELISA). Younger aged C57BL/6 female mice exhibited the highest rate and severity of metal sensitivity lymphocyte responses that also translated into higher PIO compared to any other experimental group. The absence of inflammasome/caspase-1 activity significantly suppressed DTH metal-reactivity and osteolysis in both male and female Caspase-1 deficient mice. These murine model results indicate that young female mice are more predisposed to metal-DTH augmented inflammatory responses to wear debris, which is highly influenced by active NLRP3 inflammasome/caspase-1 danger signaling. If these results are clinically meaningful for orthopedic patients, then younger female individuals should be appropriately assessed and followed for DTH derived peri-implant complications.

Indexed as

Age FactorsAnimalsBone ResorptionCaspase 1FemaleHumansHypersensitivityImmunity, InnateInflammasomesInterferon-gammaInterleukin-17MacrophagesMaleMetalsMiceNLR Family, Pyrin Domain-Containing 3 ProteinCasp1 protein, mouseCaspase 1IFNG protein, mouseInflammasomesInterferon-gammaInterleukin-17MetalsNLR Family, Pyrin Domain-Containing 3 Protein

Identifiers

PMID34003868
PMCPMC8130946
OpenAlexW3162086228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.